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Abstract 
Amniotic fluid embolism (AFE) is one of the most devastating complications of 
pregnancy that typically manifests as acute cardiopulmonary collapse during 
delivery or in the postpartum period. The potential role of extracorporeal 
membrane oxygenation (ECMO) as a management technique in severe cases of 
AFE remains largely unknown. In this report, we present the first case, to our 
knowledge, of successful implementation of ECMO as a life-saving measure in a 
case of hemorrhagic shock due to postpartum bleeding complicated by severe 
AFE leading to acute respiratory distress syndrome (ARDS) ultimately requiring 
tracheostomy. Hemodynamic decompensation is often rapid but transient in cases 
of severe AFE, and we recommend early consideration of ECMO implementation 
given its vital utility in these critical moments.  
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Introduction 
Extracorporeal membrane oxygenation (ECMO) was initially used as long-term 
support for severe respiratory failure in the 1970s. Widespread ECMO use had not 
been considered until the relatively recent CESAR trial described significant 
improvement in mortality and disability following ECMO intervention compared to 
conventional ventilatory support (1). Over the interval of four decades, limited 
randomized controlled trials have been completed investigating ECMO applicability 
(1-4). Therefore, much remains unknown about the potential utility of ECMO in 
various clinical settings.  
Amniotic fluid embolism (AFE), reported as early as 1926, has an incidence of 1 in 
40,000 deliveries with a mortality that can approach 60% (5, 6). AFE heralds from 
a breach in the maternal-fetal barrier during parturition leading to fetal tissue 
exposure to the mother resulting in a complex clinical presentation (Figure 1).  
Figure 1 
Pathophysiology of amniotic fluid embolism 
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Clinical manifestations typically seen include hypoxia, hypotension and 
coagulopathy, which can rapidly progress resulting in cardiac arrest and death (7). 
AFE is often diagnosed on clinical suspicion, and proceeding with emergent 
management is necessary since hemodynamic decompensation may be transient 
and recoverable within hours (8).  
The foundation of maintaining hemodynamic support is essential in AFE 
intervention, focusing on blood pressure augmentation and oxygenation support. 
There is a paucity of literature describing advanced hemodynamic support in 
cases of AFE, with isolated reports of survival associated with the use of ECMO, 
intra-aortic balloon counter pulsation, and continuous hemodiafiltration have been 
described but are still currently generally regarded as experimental approaches (8-
11). 
To our knowledge, the case we present here is the first report of AFE-induced 
hemorrhagic shock successfully managed with veno-venous (VV) ECMO in a 
patient with anti-cardiolipin antibody syndrome.  
Case 
A 37-year-old G3P0020 female with known anti-cardiolipin antibodies being 
managed with low molecular weight heparin and aspirin during pregnancy was 
admitted to the hospital for induction of labor in the 39th week of gestation. On 
hospital day two, a Caesarian section was performed, which was complicated by 
severe post-partum hemorrhage requiring massive transfusion, tranexamic acid 
and uterine tamponade.  
Despite anticoagulation being held 24 hours prior to the procedure, within one hour 
of Caesarian section the patient developed post-partum hemorrhage requiring 
blood products. Hemodynamic instability persisted leading to hypoxic respiratory 
failure ultimately requiring intubation within six hours of the procedure. The patient 
remained hypoxic and cyanotic on maximal ventilator settings and profoundly 
hypotensive. In addition, she experienced recurrent bleeding that necessitated 
emergent bedside hysterectomy. AFE was suspected due to the sudden dire 
hypoxia and hypotension, and she was subsequently placed on VV ECMO within 
12 hours of Caesarian section. The double cannulas were placed in the bilateral 
femoral veins, and anticoagulation with heparin was initiated to support ECMO. 
On post-operative day one, she continued to require blood products while 
remaining ventilator-dependent, with chest X-ray findings suggestive of ARDS. 
Blood pressure was maintained in acceptable range with vasopressor support. 
She required multiple trips to the operating room for abdominal exploration and 
washout due to intra-abdominal bleeding requiring institution of massive 
transfusion protocol. Due to persistent post-partum hemorrhage, ECMO was 
continued without anticoagulation. Eventually, bleeding was controlled and vital 
signs began to show improvement. Electrolytes, renal function, and hepatic 
parameters remained preserved during the hospital course. After 10 days, the 
patient was decannulated and taken off ECMO support, and she was discharged 
home with minimal sequelae. 
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Discussion 
 
This report describes a unique presentation of AFE-induced hemorrhagic shock 
and profound bleeding that required advanced life support measures in the form of 
ECMO. This case complements an extremely limited literature base discussing the 
potential utility of ECMO in the management of AFE.  Furthermore, to our 
knowledge, this is the first report of ECMO support in the management of AFE-
induced hemorrhagic shock in a patient with a known hypercoagulable disorder.  
 
AFE was suspected to be the etiology of hemodynamic compromise in this case 
because of the clinical presentation with marked rapid decline in the hours shortly 
following Caesarian section. During this interval and prior to transfusion of blood 
products, critical hypoxia and hypotension persisted despite maximal support. In 
addition, pathological analysis of uterus and placenta samples was suggestive of 
placenta accreta, which is an established risk factor for AFE (12-14).  
The underlying diagnosis of anticardiolipin antibody syndrome likely significantly 
contributed to the patient’s challenging hospital course. Her hematological disorder 
predisposed her to profound bleeding, leading to critical hemorrhage during and 
after Caesarian delivery. Recurrent bleeding required several emergent trips to the 
operating room leading to the decision to run the ECMO circuit without heparin. 
After stopping anticoagulation within hours of initiating ECMO, the relative 
frequency of bleeding episodes gradually declined. She was subsequently 
successfully maintained on the VV ECMO circuit without anticoagulation for 
approximately five days. Clotting within the ECMO circuit or the oxygenator was 
not observed during this time. On post-operative day six, post-partum bleeding had 
ceased with blood levels stable, and the surgical team closed the abdomen. 
Heparin was resumed for the remaining ECMO course without complication.  
The timely incorporation of ECMO reversed an ill-fated hospital course of a patient 
with suspected AFE complicated by severe hemorrhagic shock and ARDS with 
persistent hypoxia despite maximal ventilator settings and paralysis. Risks 
associated with ECMO use in this setting include increased risk of bleeding in the 
setting of disseminated intravascular coagulation. However, hemodynamic 
decompensation is often rapid in cases of severe AFE, and we recommend early 
consideration of emergent ECMO implementation given its vital utility in these 
critical moments.  
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